However, some mild side effects may occur, especially during the adjustment period or at higher doses: Headaches Temporary injection site irritation Lightheadedness Water retention (in rare cases) Mild tingling or numbness (from elevated IGF-1) Ipamorelin induced growth hormone release without elevating cortisol or ACTH levels, suggesting minimal off-target effects. Raun et al., European Journal of Endocrinology Compared to Other Peptides Unlike GHRP6 , which often causes intense hunger and spikes in prolactin , or GHRP2 , which can increase cortisol , Ipamorelin is more targeted and stable
GLP-1 agonists are resistant to degradation by DPP-4
These drugs were well tolerated by our subjects, without alterations in immunosuppressive therapy and with improvement in metabolic control and anthropometric parameters
For general recovery, track sleep quality, energy levels, and exercise recovery times
Tesamorelin has FDA approval for adult visceral fat reduction, Phase III randomized trial data, and a documented metabolic improvement profile